The #1 AI-powered therapy

notes – done in seconds

Try for free

The #1 AI-powered therapy notes – done in seconds

Try for free

This blog is brought to you by YUNG Sidekick –

the #1 AI-powered therapy notes – done in seconds

This blog is brought to you by YUNG Sidekick — the #1 AI-powered therapy notes – done in seconds

Try for free – no credit card required

Home

Blog

Therapy

Differential Diagnostic Framework for Non-Psychotic Hallucinations in Clinical Practice

Stanley Efrem

Dec 12, 2025

A high-functioning professional sits in your office describing vivid visual hallucinations of people in their peripheral vision at night. They maintain intact reality testing, show no delusions, and express genuine fear about "going schizophrenic." Their MRI reveals nothing unusual. What's the real story here?

Here's what makes this case remarkable: 12.6% of people with non-psychotic disorders experience hallucinations [2]. This challenges one of our most dangerous clinical assumptions—that hallucinations automatically signal psychosis.

Hallucinations extend far beyond psychotic disorders, appearing in non-psychotic conditions and sometimes occurring in completely normal states [2]. Research documents a 9.6% lifetime prevalence for non-clinical auditory verbal hallucinations across age groups [19]. These experiences typically surface a few times weekly, lasting minutes per episode [19].

Your clinical instinct matters here. When patients report hallucinations, resist the immediate leap to psychosis. Think of yourself as mapping unexplored territory. Auditory hallucinations appear across multiple psychiatric conditions: borderline personality disorder (40%), mood disorders (45%), anxiety disorders (14%), and post-traumatic stress disorder (15%) [20].

Four distinct categories emerge when you examine hallucinations systematically: Neurological causes, Substance/Medication-Induced effects, Psychiatric Non-Psychotic origins, and Sensory Deprivation phenomena. This framework helps you identify the true source, prevent misdiagnosis, and select appropriate interventions for your patients facing these complex symptoms.

Each category requires different clinical approaches. Miss the distinction, and you risk prescribing antipsychotics for bereavement hallucinations or overlooking temporal lobe epilepsy in someone you might otherwise label as psychotic.

Phenomenological Interview Guide for Hallucination Assessment

Detailed phenomenological assessment forms the foundation of accurate hallucination diagnosis. This systematic approach to understanding subjective experience provides the information you need to move beyond reflexive assumptions about psychosis.

Sensory Modality: Visual, Auditory, Olfactory, Tactile

Your first diagnostic clue comes from identifying which senses are involved. Auditory hallucinations occur most frequently (29.5%), followed by visual (21.5%), tactile (19.9%), and olfactory hallucinations (17.3%) [21]. Nearly half of those experiencing hallucinations report multimodal hallucinations (MMHs) affecting two or more senses simultaneously (47.6%) [21].

Essential questions for each modality:

Auditory: "Do you hear voices or sounds when no one is present? Are they inside or outside your head? Do these sounds have speech-like qualities or are they non-verbal noises?"
Visual: "Do you see things that others cannot see? Are they formed images (people/objects) or unformed (lights/shadows)?"
Tactile: "Do you feel sensations on or in your body that don't have an external cause? Where are these sensations located?"
Olfactory: "Do you smell odors that others cannot detect? Are these smells pleasant or unpleasant?"

Pay attention to whether hallucinations occur across multiple senses simultaneously or separately. When they happen together, ask if they seem to come from the same source—this pattern appears more commonly in psychotic disorders [3].

Locus and Timing: Hypnagogic, Hypnopompic, or Continuous

Sleep-wake cycle timing offers crucial diagnostic information. About one in ten people experience hallucinations primarily while falling asleep (hypnagogic) or waking up (hypnopompic) [21]—strong indicators of non-psychotic origins.

Key timing questions:

"When do these experiences typically occur? Are they more common when you're falling asleep or waking up?"
"How long do these experiences last? Seconds, minutes, or hours?"
"What is your level of consciousness during these experiences? Fully awake, drowsy, or transitioning between sleep and wakefulness?"

The DSM-5 specifically excludes sleep-related perceptions from the hallucination category, stating "the term hallucination is not ordinarily applied to false perceptions that occur during dreaming, while falling asleep (hypnagogic), or upon awakening (hypnopompic)" [3].

Insight and Emotional Response: Preserved vs. Impaired

Insight levels significantly guide your differential diagnosis. Only 10.2% of those with auditory hallucinations and 11.4% with visual hallucinations remain nearly fully convinced their perceptions are real [21]. Preserved insight typically rules out primary psychotic disorders.

Critical insight assessment points:

"What do you make of these experiences? Do you recognize them as not being real, or do they seem completely real to you?"
"How distressing are these experiences for you?" (Only 10.5% with auditory and 16.8% with visual hallucinations report moderate to severe distress [21])
"How do these experiences affect your daily functioning?" (12.7% with auditory and 17.3% with visual hallucinations report functional impact [21])

Contextual Triggers: Stress, Fatigue, Substance Use

Trigger identification reveals important diagnostic patterns. Stress consistently provokes hallucinatory episodes [3]. Experience sampling studies show anxiety levels often predict increased hallucination intensity [3].

Pattern recognition questions:

"Have you noticed any patterns regarding when these experiences occur? What tends to be happening in your life during these times?"
"Do these experiences worsen during periods of high stress, poor sleep, or illness?"
"Do you use any substances or medications that might be related to these experiences?"

One in five to six people with hallucinations report content connected to previous distressing experiences [21], pointing toward trauma-related rather than psychotic origins.

This systematic assessment creates your diagnostic roadmap, guiding you toward the appropriate category among our four main causes.

Neurological Causes of Hallucinations: Rule Out First

Neurological conditions masquerading as psychiatric disorders represent one of medicine's most dangerous diagnostic traps. Missing a temporal lobe seizure or early Lewy body dementia while treating hallucinations as primary psychosis can delay critical interventions for potentially manageable conditions.

Your neurological assessment must come first, before any psychiatric considerations. The consequences of getting this wrong extend far beyond inappropriate medication—you risk missing progressive diseases that require immediate attention.

Temporal Lobe Epilepsy and Olfactory Auras

Temporal lobe epilepsy creates distinctive sensory experiences that patients often struggle to describe. Olfactory auras—unusual smell perceptions without external sources—occur in approximately 5.5% of patients with TLE [5]. These olfactory hallucinations typically register as unpleasant and frequently appear alongside epigastric rising, nausea, and intense fear [6].

Neuroimaging reveals a clear pattern: these olfactory auras correlate strongly with structural lesions in mesial temporal structures, particularly the amygdala [5]. One study examining patients with olfactory epileptic auras found that 11 out of 12 patients had structural lesions involving mesial temporal structures, with two patients showing lesions exclusively in the amygdala [6].

The clinical picture differs markedly from psychotic hallucinations. These episodes are brief and stereotyped, contrasting sharply with the prolonged, varied nature of psychotic experiences. Post-surgical outcomes confirm the temporal lobe origin—patients undergoing temporal lobectomy often experience complete resolution of their olfactory auras [6].

Lewy Body Dementia and Formed Visual Hallucinations

Visual hallucinations serve as a cornerstone diagnostic feature of Lewy body dementia, occurring in 55% to 78% of patients [7]. These hallucinations typically emerge early in the disease course, making them invaluable diagnostic indicators.

LBD visual hallucinations display characteristic features: formed, detailed images of people, animals, or objects that appear three-dimensional and vividly colored [8]. Patients may describe "passage hallucinations"—shadows or movements glimpsed in peripheral vision—or "presence hallucinations"—the sensation that someone lurks nearby [8].

Timing provides crucial diagnostic information. Visual hallucinations occurring within five years of developing dementia increase the odds of pathology-confirmed Lewy body disease 4-5 times over Alzheimer's disease [9]. Early hallucination onset essentially shifts your diagnostic probability significantly.

Narcolepsy Type 1: Hypnagogic/Hypnopompic Hallucinations

Narcolepsy type 1 creates a unique neurological profile combining excessive daytime sleepiness, cataplexy, and distinctive hallucinations. These perceptual experiences occur during sleep-wake transitions—hypnagogic when falling asleep or hypnopompic when awakening [10].

The hallucinations predominantly involve vivid visual experiences (86% of cases), with auditory perceptions (8-34%) and tactile sensations also reported [11]. Patients describe flashing lights, geometric shapes, or detailed images of people and animals [11]. Many report sensations of weightlessness, flying, falling, or sensing an invisible presence in the room [11].

The underlying physiology explains these experiences: abnormal REM sleep intrusions into wakefulness. Narcolepsy patients enter REM sleep within 15 minutes of sleep onset, compared to 90 minutes in healthy individuals, blurring the boundary between sleep and wakefulness [11]. Dream-like content consequently bleeds into conscious awareness.

Posterior Cortical Atrophy and Visual Misperceptions

Posterior cortical atrophy affects the occipital, parietal, and posterior temporal lobes [1]. While primarily linked to Alzheimer's pathology, PCA creates distinctive visual processing abnormalities that can appear identical to hallucinations.

The condition progressively impairs higher visual functions, producing various misperceptions. Simultanagnosia—inability to perceive multiple visual elements simultaneously—affects over 90% of PCA patients [1]. This creates a fragmented visual experience where objects seem to materialize and vanish unpredictably.

Patients may also experience the "reverse-size phenomenon," paradoxically finding small letters easier to read than large ones [1]. Visual misperceptions can advance to the point where patients mistake parts of objects for entirely different items [1].

These experiences result from impaired visual processing rather than true perceptions without stimuli. However, they require careful assessment to distinguish from primary hallucinatory disorders.

The Stakes Are Too High

Thorough neurological workup—including MRI, EEG, and appropriate laboratory tests—remains standard care before making any psychiatric diagnosis in patients with new-onset hallucinations. Skip this step, and you risk catastrophic misdiagnosis with delayed treatment of potentially manageable neurological conditions.

Substance and Medication-Induced Hallucinations

Prescription drugs cause hallucinations more often than most clinicians realize. These perceptual disturbances emerge from direct pharmacological effects or withdrawal states, making thorough medication review essential for accurate diagnosis.

Common Prescription Triggers: Anticholinergics, Dopaminergics

Several prescription categories regularly produce hallucinations through established mechanisms. Steroids, antiepileptic drugs, antimalarial medications, and antiretrovirals trigger psychotic symptoms, with persecutory delusions and auditory hallucinations reported most frequently [12]. Mood changes and anxiety typically appear before psychotic symptoms develop following steroid or antimalarial administration.

Parkinson's disease medications require special diagnostic consideration. Dopaminergic agents, combined with disease progression, create conditions ripe for hallucinatory experiences. These hallucinations look different from classic anticholinergic or acute aminergic states [13]. Here's what makes this particularly complex: adjusting either dopaminergic or anticholinergic medications can trigger or eliminate hallucinations in the same patient, indicating these systems work together to produce drug-induced hallucinations.

This creates a clinical dilemma for PD patients experiencing hallucinations. Many conventional antipsychotics can worsen motor symptoms [14]. Dopamine stabilizes motor function but can increase psychological side effects at higher doses—a delicate balance requiring careful management.

Withdrawal States: Alcohol, Benzodiazepines

Sudden benzodiazepine discontinuation, particularly from high daily doses, can produce acute psychotic illness with agitation, confusion, and disorientation [15]. Benzodiazepine withdrawal creates multiple perceptual disturbances:

Hypnagogic hallucinations
Auditory disturbances
Visual disturbances
Tactile sensations
Depersonalization and derealization

Severe benzodiazepine withdrawal may progress to delirium, seizures, or coma in rare cases [16]. The presentation closely mimics primary psychotic disorders but responds well to appropriate withdrawal management.

Alcohol withdrawal presents similarly through alcoholic hallucinosis or the more severe delirium tremens. These states typically resolve with proper withdrawal management, though delirium tremens carries a 1-5% mortality rate [17].

Over-the-Counter and Herbal Agents to Screen For

Non-prescription substances complicate the diagnostic picture significantly. Half the US population uses dietary supplements, with three-quarters taking them without physician guidance [18]. Many patients don't mention supplement use during evaluations.

Several OTC medications produce hallucinations when misused:

Antihistamines at high doses [2]
Dextromethorphan (DXM), especially at recreational doses [2]
Cold medications containing phenylpropanolamine [19]

Herbal supplements pose underrecognized hallucination risks. One case involved a 43-year-old man with no psychiatric history who developed six months of visual and auditory hallucinations after taking multiple supplements simultaneously [20]. The interaction between various herbal ingredients likely caused his symptoms, which resolved after discontinuation.

Thorough substance assessment becomes crucial when evaluating hallucinations. Symptoms often clear once the triggering medication leaves the body, though psychosis from amphetamines, cocaine, or PCP may persist for weeks [21]. This timing relationship helps distinguish substance-induced from primary psychotic disorders.

Psychiatric Non-Psychotic Hallucinations: Trauma and Mood

Hallucinations appear across multiple psychiatric conditions without indicating psychosis. Recognizing these presentations protects patients from misdiagnosis and prevents treatments that could worsen their symptoms.

Dissociative Voice-Hearing in PTSD and DID

Trauma creates its own perceptual landscape. Voice hearing appears frequently in trauma spectrum disorders like PTSD and dissociative identity disorder [3]. These trauma-based hallucinations carry distinct features:

Voices connect thematically to trauma experiences but stay separate from flashbacks [3]
Half of PTSD patients can identify whose voices they're hearing [3]
Chronic PTSD voices often command self-harm or express harsh criticism [3]

The relationship between voices and other trauma symptoms tells its own story. One patient described: "Just before I have the flashback, I'll feel like the dark voice is saying, like, 'here we go'" [22]. Sometimes voices appear after flashbacks with supportive messages. Dissociative episodes and voice-hearing often occur together, with dissociation helping patients manage the distress these voices create [22].

These hallucinations can be as vivid and "real" as those in schizophrenia [3]. The loudness, negative content, and distress levels may exceed what you see in primary psychotic disorders [3].

Mood-Congruent Hallucinations in Depression and Mania

Mood disorders shape their own hallucinatory experiences. Psychosis appears more often during manic episodes but can emerge in severe depression too [23]. These hallucinations display "mood congruence"—they match and amplify the person's emotional state [24].

Manic episodes produce:

Grandiose delusions about special powers or abilities
Hallucinations that reinforce feelings of invincibility or importance [24]

Depressive episodes generate different content:

Hallucinations emphasizing worthlessness, failure, or impending doom
Delusional thoughts focused on guilt, punishment, or irreparable flaws [24]

This content-mood alignment offers a key diagnostic marker. These hallucinations typically fade as the mood episode stabilizes.

Bereavement Hallucinations with Preserved Insight

Loss creates its own perceptual experiences. "Sensory and quasi-sensory experiences of the deceased" affect between 47% to 82% of bereaved individuals [25]. Unlike psychotic hallucinations, these experiences maintain insight and often bring comfort rather than distress.

The most common experience involves "feeling the presence" of the deceased (39% of widows/widowers). Visual hallucinations follow (14%), then auditory verbal hallucinations (13.3%), and tactile sensations (2.7%) [26].

These experiences take several forms:

Hearing the deceased person's voice offering guidance
Brief visual appearances of the loved one
Feeling touched or embraced by the person who died
Smelling distinctive scents associated with the deceased [25]

Bereavement hallucinations represent normal grief responses rather than pathological experiences. Cultural factors influence both their frequency and meaning [27]. They typically support grief resolution, helping people maintain connection with their loved one while adapting to the loss.

Your assessment must explore trauma history and recent losses. Skip these questions, and you risk labeling normal grief responses or trauma reactions as psychotic disorders.

Sleep-Related and Sensory Deprivation Phenomena

Sleep transitions create a surprising number of hallucinatory experiences that have nothing to do with mental illness. These phenomena occur in healthy individuals and require recognition to prevent unnecessary psychiatric diagnoses.

Hypnagogic and Hypnopompic Hallucinations in Sleep Disorders

Two types of sleep-related hallucinations appear at predictable times. Hypnagogic hallucinations occur while falling asleep, and hypnopompic hallucinations happen during awakening [4]. The numbers tell an important story—hypnagogic hallucinations affect up to 37% of people, while hypnopompic hallucinations occur in over 12% [28].

Visual experiences dominate these episodes (86% of cases), featuring geometric patterns, light flashes, or detailed images of people and animals [29]. Auditory components appear less frequently (8-34%), typically involving voices, bells, or environmental sounds [30]. Tactile sensations round out the experience (25-44%), with reports of weightlessness, flying, falling, or sensing another presence [28].

The DSM-5 makes this distinction clear: hallucinations occurring during sleep transitions should not be considered pathological [4]. Stress can intensify these experiences, making accurate differential diagnosis essential for your practice.

Hallucinations in Sensory Deprivation: Darkness, Isolation

Your brain requires constant sensory input to function properly. Without it, predictable things happen. Extended darkness or isolation triggers hallucinatory experiences through well-understood neurological mechanisms. The brain continues processing nerve signals but struggles to organize limited information coherently [31]. This leads to fantasy perceptions constructed from minimal sensory data.

Research consistently demonstrates these effects. Volunteers isolated in soundproofed rooms for 48 hours developed anxiety, paranoia, and vivid hallucinations of objects, animals, and environmental changes [31]. Even brief sensory restriction produces results—19 volunteers placed in a dark, soundproof booth for just 15 minutes reported seeing faces, shapes, and sensing "presences" [32].

Overlap with Anxiety-Induced Somatic Hallucinations

Anxiety disorders create their own hallucinatory experiences through specific mechanisms. During heightened anxiety states, the brain struggles to distinguish internal thoughts from external sensory input [33]. This confusion can transform thoughts or mental imagery into perceived reality across multiple sensory modalities.

Sleep disturbances compound the problem. Anxiety-induced insomnia creates sleep deprivation, which increases hallucination vulnerability [34]. Patients with anxiety-related hallucinations typically describe brief perceptual distortions occurring exclusively during extreme stress or exhaustion [34]. This pattern clearly separates them from psychotic hallucinations.

Recognition matters here. These benign phenomena don't require antipsychotics. Instead, focus your interventions on sleep hygiene, anxiety management, and patient education. Simple explanations often provide tremendous relief for patients experiencing these normal but frightening phenomena.

Documentation and First-Line Management Before Diagnosis

Your documentation strategy determines patient safety when hallucinations appear in clinical practice. Proper records serve as your diagnostic roadmap, particularly when the underlying cause remains unclear.

Sample Language for Open Differential Documentation

Precise documentation matters more than diagnostic certainty at initial presentation. Vague statements offer no clinical value. Effective documentation includes specific details:

"Patient reports visual hallucinations consisting of formed images of people in peripheral vision, occurring exclusively at night, with preserved insight into their non-reality. No command hallucinations or associated delusions. Patient expresses fear these experiences might indicate schizophrenia."

This sample captures essential diagnostic elements: modality, content, timing, insight level, and patient concerns. Document that your differential diagnosis remains open. Multiple potential causes deserve consideration at this stage.

Initial Workup: EEG, MRI, Toxicology

New-onset hallucinations require standard diagnostic testing. These aren't optional screening tools—they're essential safety measures:

EEG: Often the most revealing initial study. Detects seizure activity, delirium patterns (theta-delta slowing), delirium tremens (rapid beta activity), or Creutzfeldt-Jakob disease (occipital periodic complexes) [36].

Brain MRI: Necessary to identify tumors or infarcts indicating Anton's syndrome or peduncular hallucinosis [36].

Toxicology screening: Critical step since substance-induced symptoms rank among the most common medical causes of acute psychotic presentations [37].

First-episode cases need expanded testing: metabolic panels, thyroid function studies, and infection screening [38].

Psychoeducation and Reassurance as First-Line Response

Most patients experiencing hallucinations benefit from initial reassurance [36]. Psychoeducation offers low-risk intervention [39] and should precede medication trials except in dangerous situations.

Charles Bonnet Syndrome responds well to education about the benign nature of visual hallucinations [40]. Even serious mental health conditions improve with psychoeducation—better treatment satisfaction, fewer relapses, enhanced quality of life [39].

Schedule follow-up within 1-2 weeks after any intervention. Monitor treatment response, assess side effects, watch for emerging symptoms [40]. This approach protects patient safety while preserving diagnostic flexibility.

Your patients depend on systematic assessment rather than diagnostic assumptions. Take time to gather the complete clinical picture before determining treatment direction.

Conclusion

Remember that high-functioning professional from the opening case? Their night-time visual hallucinations of people in peripheral vision, coupled with preserved insight and clean MRI, likely point toward sleep-related phenomena or anxiety-induced experiences rather than psychosis. Your systematic assessment framework now provides the tools to reach this conclusion confidently.

This diagnostic approach protects both you and your patients. When you differentiate between neurological, substance-induced, psychiatric non-psychotic, and sensory-related causes, you prevent potentially harmful misdiagnosis. Missing temporal lobe epilepsy or Lewy body dementia carries devastating consequences. Prescribing antipsychotics for bereavement hallucinations or sleep-related phenomena creates unnecessary risks.

Your clinical skills matter here. Careful assessment of phenomenological characteristics—modality, timing, insight level, and contextual triggers—guides accurate diagnosis. Neurological evaluation comes first with new-onset hallucinations. Medication screening catches common but overlooked causes. Trauma history and bereavement status reveal normal or expected experiences that don't require psychiatric intervention.

Documentation practices reflect your diagnostic precision. Detailed descriptions of hallucination characteristics, appropriate workups, and patient education establish responsible clinical care while keeping diagnostic options open.

The best clinicians approach hallucinations with curiosity rather than assumptions. This complex symptom requires careful mapping across multiple domains. When you resist equating hallucination with psychosis, you protect patients from misdiagnosis, inappropriate medications, and delayed treatment of manageable conditions.

Stay curious. Ask detailed questions. Rule out medical causes first. Your patients depend on this diagnostic precision to receive appropriate care rather than labels that don't fit their actual experience.

Key Takeaways

Hallucinations don't automatically indicate psychosis—this comprehensive framework helps clinicians avoid dangerous misdiagnosis and provide appropriate care for patients experiencing complex perceptual symptoms.

• Rule out neurological causes first: Temporal lobe epilepsy, Lewy body dementia, and narcolepsy can all cause hallucinations that mimic psychiatric disorders but require completely different treatments.

• Conduct thorough medication review: Prescription drugs (anticholinergics, dopaminergics), withdrawal states, and even OTC supplements frequently trigger hallucinations that resolve once identified and managed.

• Assess phenomenological characteristics systematically: Document sensory modality, timing (hypnagogic/hypnopompic vs. continuous), insight level, and contextual triggers to differentiate between psychotic and non-psychotic causes.

• Recognize trauma-based and mood-related hallucinations: PTSD, dissociative disorders, depression, and normal bereavement can all produce vivid hallucinations with preserved insight that don't require antipsychotic treatment.

• Use psychoeducation and reassurance as first-line interventions: Most patients benefit from understanding their experiences before medication, with comprehensive workup (EEG, MRI, toxicology) guiding appropriate treatment decisions.

Remember: The hallucination is not the diagnosis—it's a symptom requiring careful detective work to uncover its true origin and guide proper treatment.

FAQs

What are some common non-psychotic causes of hallucinations?

Non-psychotic causes of hallucinations can include neurological conditions like temporal lobe epilepsy and Lewy body dementia, medication side effects, substance use or withdrawal, sleep disorders, and sensory deprivation. Trauma-related disorders and mood disorders can also produce hallucinations without indicating psychosis.

How can clinicians differentiate between psychotic and non-psychotic hallucinations?

Clinicians can differentiate by assessing the hallucination's sensory modality, timing (e.g., sleep-related or continuous), the patient's level of insight, and any contextual triggers. Non-psychotic hallucinations often occur with preserved insight, may be linked to specific situations or times of day, and typically lack associated delusions.

What initial steps should be taken when a patient reports new-onset hallucinations?

When a patient reports new-onset hallucinations, clinicians should first rule out neurological causes through tests like EEG and MRI. A thorough medication review, toxicology screening, and detailed assessment of the hallucination characteristics are also crucial. Providing psychoeducation and reassurance is often a beneficial first-line response.

Are hallucinations always a sign of mental illness?

No, hallucinations are not always a sign of mental illness. They can occur in various non-pathological states, including during sleep transitions (hypnagogic/hypnopompic hallucinations), in sensory deprivation conditions, or as part of normal grief processes. Some hallucinations may also be side effects of medications or substances.

How common are hallucinations in the general population?

Hallucinations are more common in the general population than often assumed. For example, hypnagogic hallucinations (occurring while falling asleep) affect up to 37% of people, while hypnopompic hallucinations (occurring while waking up) occur in over 12%. Non-clinical auditory verbal hallucinations have a lifetime prevalence of about 9.6% across different age groups.